Predict your next investment

MindMaze company logo
Corporation
HEALTHCARE | Medical Devices & Equipment
mindmaze.com

See what CB Insights has to offer

Total Raised

$243.5M

Investors Count

3

Deal Terms

3

MindMaze Funding, MindMaze Valuation & MindMaze Revenue

5 Fundings

MindMaze's latest funding round was a Series B for $125M on October 7, 2021.

MindMaze's valuation in June 2012 was $100M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/7/2021

Series B

$125M

$0.00B

((9.99x))

FY 1234

6

9/22/2017

Angel

$99M

$0.00B

((9.99x))

FY 1234

10

1/28/2016

Corporate Minority

$99M

$0.00B

((9.99x))

FY 1234

10

3/4/2015

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

6/1/2012

Seed

$99M

$100M

$0.00B

((9.99x))

FY 1234

10

Date

10/7/2021

9/22/2017

1/28/2016

3/4/2015

6/1/2012

Round

Series B

Angel

Corporate Minority

Series A

Seed

Amount

$125M

$99M

$99M

$99M

$99M

Investors

Valuation

$100M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

6

10

10

10

10

MindMaze Deal Terms

3 Deal Terms

MindMaze's deal structure is available for 3 funding rounds, including their Corporate Minority from January 28, 2016.

Round

Corporate Minority

Series A

Seed

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Corporate Minority

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

Seed

MindMaze Investors

3 Investors

MindMaze has 3 investors. AlbaCore Capital invested in MindMaze's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/7/2021

10/7/2021

1
Series B

Asset/Investment Management

United Kingdom

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Angel Investor (Individual)

United States

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporation

India

First funding

10/7/2021

00/00/0000

00/00/0000

Last Funding

10/7/2021

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

1
Series B

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Asset/Investment Management

Angel Investor (Individual)

Corporation

Location

United Kingdom

United States

India

MindMaze Acquisitions

2 Acquisitions

MindMaze acquired 2 companies. Their latest acquisition was Neuro Motor Innovations on November 14, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/14/2018

Acquired

1

6/8/2017

Incubator/Accelerator

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/14/2018

6/8/2017

Investment Stage

Incubator/Accelerator

Companies

Subscribe to see more

Valuation

Total Funding

$99M

Note

Acquired

Subscribe to see more

Sources

1

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.